How bacteria and their products provide clues to vaccine and adjuvant development

被引：9

作者：

Dougan, G ^{[1
]}

Hormaeche, C ^{[1
]}

机构：

[1] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England

来源：

VACCINE | 2006年 / 24卷

基金：

英国惠康基金;

关键词：

adjuvant; PAMP; TLR pathway; lipopolysaccharide; CpG;

D O I：

10.1016/j.vaccine.2005.01.104

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Evidence has emerged that both vertebrates and invertebrates share innate immune pathways involved in the recognition of and the response to micro-organisms, including bacteria and their products. As a consequence, particular degenerate products of bacteria can stimulate and modulate immune responses and influence acquired immunity and, potentially, protection against disease. New knowledge in this field is beginning, to explain how vaccine adjuvants work and will facilitate the future development of novel adjuvants and vaccines. (c) 2005 Elsevier Ltd. All rights reserved.

引用

页码：S13 / S19

页数：7

共 66 条

[1] Toll-like receptors in the induction of the innate immune response [J].

Aderem, A ;

Ulevitch, RJ .

NATURE, 2000, 406 (6797) :782-787

[2]

Agren LC, 1997, J IMMUNOL, V158, P3936

[3] Safety evaluation of a new allergy vaccine containing the adjuvant monophosphoryl lipid a (MPL®) for the treatment of grass pollen allergy [J].

Baldrick, P ;

Richardson, D ;

Wheeler, AW ;

Woroniecki, SR .

JOURNAL OF APPLIED TOXICOLOGY, 2004, 24 (04) :261-268

[4] Taking a Toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents [J].

Baldridge, JR ;

McGowan, P ;

Evans, JT ;

Cluff, C ;

Mossman, S ;

Johnson, D ;

Persing, D .

EXPERT OPINION ON BIOLOGICAL THERAPY, 2004, 4 (07) :1129-1138

[5]

Bazin H., 1999, ERADICATION SMALLPOX

[6] Immunological foundations to the quest for new vaccine adjuvants [J].

Burdin, N ;

Guy, B ;

Moingeon, P .

BIODRUGS, 2004, 18 (02) :79-93

[7]

Chabalgoity Jose A, 2002, Expert Rev Vaccines, V1, P495, DOI 10.1586/14760584.1.4.495

[8] Oral somatic transgene vaccination using attenuated S-typhimurium [J].

Darji, A ;

Guzman, CA ;

Gerstel, B ;

Wachholz, P ;

Timmis, KN ;

Wehland, J ;

Chakraborty, T ;

Weiss, S .

CELL, 1997, 91 (06) :765-775

[9]

De Magistris MT, 1998, DEV BIOLOGICALS, V92, P123

[10] DISSOCIATION OF ESCHERICHIA-COLI HEAT-LABILE ENTEROTOXIN ADJUVANTICITY FROM ADP-RIBOSYLTRANSFERASE ACTIVITY [J].

DICKINSON, BL ;

CLEMENTS, JD .

INFECTION AND IMMUNITY, 1995, 63 (05) :1617-1623

← 1 2 3 4 5 6 7 →